标题
Inhibition of Janus kinases by tyrosine phosphorylation inhibitor, Tyrphostin AG-490
作者
关键词
-
出版物
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
Volume 33, Issue 11, Pages 2368-2379
出版商
Informa UK Limited
发表日期
2015-05-28
DOI
10.1080/07391102.2015.1050696
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Unknown
- (2016) AMERICAN JOURNAL OF TRANSPLANTATION
- Unknown
- (2016) JOURNAL OF COMPUTATIONAL CHEMISTRY
- Inhibition of JAK1, 2/STAT3 Signaling Induces Apoptosis, Cell Cycle Arrest, and Reduces Tumor Cell Invasion in Colorectal Cancer Cells
- (2015) Hua Xiong et al. NEOPLASIA
- Elimination of EGFR-expressing circulating tumor cells in patients with metastatic breast cancer treated with gefitinib
- (2014) Antonia Kalykaki et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A phase 2 study of ruxolitinib, an oral JAK1 and JAK2 inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea
- (2013) Srdan Verstovsek et al. CANCER
- Rational Design of Particle Mesh Ewald Compatible Lennard-Jones Parameters for +2 Metal Cations in Explicit Solvent
- (2013) Pengfei Li et al. Journal of Chemical Theory and Computation
- Inhibition of protein kinase C βII isoform ameliorates methylglyoxal advanced glycation endproduct-induced cardiomyocyte contractile dysfunction
- (2013) Liwei Zhang et al. LIFE SCIENCES
- The Tyrphostin Agent AG490 Prevents and Reverses Type 1 Diabetes in NOD Mice
- (2012) Abdoreza Davoodi-Semiromi et al. PLoS One
- JAK2 inhibitors: What's the true therapeutic potential?
- (2010) Fabio P.S. Santos et al. BLOOD REVIEWS
- Tyrphostins as Potential Therapeutic Agents for Acute Kidney Injury
- (2010) S. Goncalves et al. CURRENT MEDICINAL CHEMISTRY
- C-peptide stimulates nitrites generation via the calcium-JAK2/STAT1 pathway in murine macrophage Raw264.7 cells
- (2010) Soo Kyung Lee et al. LIFE SCIENCES
- Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis
- (2010) Srdan Verstovsek et al. NEW ENGLAND JOURNAL OF MEDICINE
- Phase 2 study of CEP-701, an orally available JAK2 inhibitor, in patients with primary or post-polycythemia vera/essential thrombocythemia myelofibrosis
- (2009) F. P. S. Santos et al. BLOOD
- Ensembl 2009
- (2008) T. J. P. Hubbard et al. NUCLEIC ACIDS RESEARCH
- Canonical and non-canonical JAK–STAT signaling
- (2008) Willis X. Li TRENDS IN CELL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now